Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo
about
Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats.Hydration state controls stress responsiveness and social behavior.The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress.Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasone.Gene expression profiling following maternal deprivation: involvement of the brain Renin-Angiotensin system.Lower frequency of antidepressant use in patients on renin-angiotensin-aldosterone system modifying medications.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.Chronic stress impacts the cardiovascular system: animal models and clinical outcomes.Strain differences and the role of AT(1) receptor expression in anxietyAngiotensin converting enzyme inhibition reduces cardiovascular responses to acute stress in myocardially infarcted and chronically stressed rats.Chronic overexpression of angiotensin-(1-7) in rats reduces cardiac reactivity to acute stress and dampens anxious behavior.MEMRI reveals altered activity in brain regions associated with anxiety, locomotion, and cardiovascular reactivity on the elevated plus maze in the WKY vs SHR rats.Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress.Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker.The brain as a target for development of new class of drugs for the treatment of somatic diseases.
P2860
Q34582334-6B72C2B7-2C0A-4419-8A3D-4F08404BB1B9Q34905839-03467927-A1F1-4F14-A05C-1D372008EAC4Q35853134-769B8E68-73F1-479C-BA01-D8FFCE56DBD7Q37099273-5BF2BFAA-7EF5-44FC-BDCA-D34657DF5443Q37214203-7DE8D314-68D1-4CF5-A373-5F83BB85873BQ37837656-13992488-79EA-45BD-ACB4-428BD25CB126Q38005611-DBD7F536-B7A1-4A43-95F8-E9737641FBEFQ38191484-5B88B0D7-7AAA-4FCC-860F-E9E2A77FAA16Q38427411-49D529DD-F4CE-406C-A6B6-98A6B1A983D9Q42717217-2423F7EE-529A-480C-A52F-295AAFD2BDD7Q42725776-D191C19F-6A8B-420D-9C78-A40D6B0C58FEQ47335475-482EB580-AC2A-4FB3-A3D1-3EF0F000D4DDQ47694178-1C336C2F-A033-4E3B-A84F-8D4257ED9C9CQ47965638-2497B762-9B34-4BFE-A8D1-095306D352E6Q48198351-877B055B-242C-466D-92B7-F84D091CA0B2Q48600369-F393D92C-691A-4443-9698-5DD834218246
P2860
Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Peripherally administered angi ...... anti-stress compounds in vivo
@ast
Peripherally administered angi ...... anti-stress compounds in vivo
@en
Peripherally administered angi ...... anti-stress compounds in vivo
@nl
type
label
Peripherally administered angi ...... anti-stress compounds in vivo
@ast
Peripherally administered angi ...... anti-stress compounds in vivo
@en
Peripherally administered angi ...... anti-stress compounds in vivo
@nl
prefLabel
Peripherally administered angi ...... anti-stress compounds in vivo
@ast
Peripherally administered angi ...... anti-stress compounds in vivo
@en
Peripherally administered angi ...... anti-stress compounds in vivo
@nl
P2093
P2860
P356
P1476
Peripherally administered angi ...... anti-stress compounds in vivo
@en
P2093
Enrique Sanchez-Lemus
Juan M Saavedra
Julius Benicky
Yuki Murakami
P2860
P356
10.1196/ANNALS.1410.006
P407
P577
2008-12-01T00:00:00Z